Rock Springs Capital Management LP Immunovant, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Immunovant, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 909,103 shares of IMVT stock, worth $25 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
909,103
Previous 1,221,309
25.56%
Holding current value
$25 Million
Previous $33.6 Million
25.56%
% of portfolio
1.0%
Previous 1.14%
Shares
11 transactions
Others Institutions Holding IMVT
# of Institutions
218Shares Held
67.1MCall Options Held
2.48MPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA6.68MShares$184 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$165 Million7.27% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$141 Million0.08% of portfolio
-
Black Rock Inc. New York, NY4.92MShares$135 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.87MShares$106 Million1.5% of portfolio
About Immunovant, Inc.
- Ticker IMVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 129,077,000
- Market Cap $3.55B
- Description
- Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...